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Abstract 
Objectives: To determine more closely the relationship between vasomotor symptoms, well-being and climacteric 
status according to the last menstrual bleeding and according to the women themselves. Methods: A population-based 
cross-sectional study was executed using a postal questionnaire. Well-being of women with and without vasomotor 
symptoms was compared, for the different menopausal statuses. All 2729 women living in a commuter suburb of 
Rotterdam aged 45-60 years were approached of whom 1947 (71.3%) responded. Well-being was measured by the 
Inventory of Subjective Health (ISH) and three subscales of the Sickness Impact Profile (SIP). Results: The results 
showed that the relationship between vasomotor symptoms and well-being was dependent on climacteric status. Pre- 
and (middle and late) postmenopausal women with vasomotor symptoms more often experienced a relatively lower 
level of well-being compared to women without these symptoms. However, when the prevalence of vasomotor 
symptoms is as its Peak, i.e. in late perimenopause, a difference in the level of well-being between women with and 
without vasomotor symptoms was absent. Conclusions: It is concluded that well-being and vasomotor symptoms were 
inversely related in all menopausal statuses except for the (late) perimenopausal phase. For this no somatic 
explanation seems plausible. A more social scientific explanation is suggested. 
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1. Introduction 
Early studies of the climacteric reported a range 
of symptoms that occur more frequently among 
women whose menstrual cycles have changed. 
These include hot flushes, night sweats, lethargy, 
forgetfulness tiredness, crying spells, irritability 
and headache [ l-41. Later studies differentiated 
between typical symptoms that are strongly re- 
lated to the climacteric (i.e. vasomotor symptoms 
and vaginal dryness) and atypical symptoms that 
are weakly associated. These atypical symptoms 
appeared to be more related to concurrent social, 
psychological and physically bothersome changes 
than to the climacteric per se [5-71. Since the 
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of the experiences of women in the climacteric 
years, other studies have addressed the association 
between climacteric and measures of well-being. 
These studies pointed out that (emotional) well- 
being is not much adversely affected by the cli- 
macteric [8- 121. However, Oldenhave et al. [13] 
recently concluded that the prevalence of vasomo- 
tor symptoms was highest in the late pre- 
menopause and early postmenopause (about 85%) 
and that this increase of vasomotor symptoms 
was related to an overall reduced level of well-be- 
ing. Apparently, equivocal conceptions of the as- 
sociation between climacteric status and 
well-being exist, when vasomotor symptoms are 
taken into account. 
The aim of our study was to examine more 
closely the relationship between vasomotor symp- 
toms and well-being for women in the separate 
climacteric status. Climacteric status was defined 
in two ways: according to self-perception and 
according to last menstrual bleeding. 
2. Methods 
This study is part of a larger study aimed at 
assessing the relationships between the climac- 
teric, well-being, women’s attitude towards 
menopause, medical attention and the use of hor- 
mone replacement therapy. The methodology of 
this study has been reported by us in detail else- 
where [lo]. In short, from the municipal authori- 
ties of Krimpen aan den IJssel, a commuter 
suburb of Rotterdam with approximately 28 000 
inhabitants, names and addresses of all 2729 
women aged 45-60 years were obtained. In May 
1990 they were sent a questionnaire; 1947 women 
responded (response 7 1.3%). The comparison be- 
tween respondents did not reveal any statistically 
significant differences in age, menopausal status, 
hysterectomy, estrogen therapy, level of educa- 
tion, work outside the home or medical attention. 
The study received approval from the Medical 
Ethical Committee of the Erasmus University and 
Academic Hospital, Dijkzigt in Rotterdam. 
Well-being was measured by two validated in- 
ventories: the Inventory of Subjective Health 
(ISH) and the Sickness Impact Profile (SIP). The 
ISH has proven to be a sensitive instrument to 
detect health problems. In recent years it has been 
used in several Dutch surveys to quantify subjec- 
tive health status [14- 161. In a large representa- 
tive study in the Netherlands Cronbach’s x 
equalled 0.87 and the ratio of the eigenvalues of 
the first and second principal component equalled 
16.2/4.4 = 3.7, both reflecting a strong unidimen- 
sional scale. The ISH includes 49 items, concern- 
ing the experience in the past 2 weeks of 
complaints like pains in the chest, shaking hands, 
headache, sneezing and less appetite. On every 
item the respondent was asked whether it had 
been experienced during the last 2 weeks. All 
items required either ‘yes’ or ‘no’ responses. The 
sum score of all responses was computed, the 
maximum score being 49. The SIP was developed 
in the United States as a behaviourally based 
measure of the impact of sickness [ 171. In this 
study, the Dutch validated version was used [lS]. 
We selected subscales at which, according to liter- 
ature [l-4] a possible effect of the climacteric on 
behaviour may be established. Therefore, we took 
the SIP subscales which measure the psycho-social 
impact on well-being: emotions, feelings and sen- 
sations (nine items), social interaction (18 items) 
and intellectual functioning and alertness (10 
items). 
Women were categorized as having vasomotor 
symptoms if they reported hot flushes and/or 
severe sweating on the questionnaire. The pres- 
ence of severe sweating was assessed by using 
both a closed and an open question, whereas the 
presence of hot flushes was assessed using an open 
question only. The closed questions were incorpo- 
rated in a symptom checklist, where the women 
could encircle either yes or no when they had 
regularly experienced a symptom during the last 2 
weeks. In the open question the women could 
indicate any symptom they experienced during the 
last 4 weeks. 
The climacteric status of women was classified 
according to menstrual pattern characteristics and 
to the number of months or years since the last 
menstrual bleeding prior to the completion of the 
questionnaire. We defined six categories [lo]. 
Women who had had a menstruation within 12 
months and whose menstrual pattern did not 
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change (premenopausal), women who had experi- 
enced a change in the menstrual cycles in the 
preceding year with a last menstrual bleeding 
occurring 3 months or less (perimenopausal I) or 
4-12 months ago (perimenopausal II), women 
whose last menstrual bleeding occurred l-2.5 
years ago (postmenopausal I), 2.5-4.5 years ago 
(postmenopausal II) and more than 4.5 years ago 
(postmenopausal III). As some women filled out 
the year of the last menstrual bleeding only and 
not the exact month, a classification was chosen 
which coincided with the calendar year. Women 
who had undergone hysterectomy and women 
who had used estrogen therapy in the 6 months 
prior to answering the questionnaire (n = 473), 
were excluded from the analyses as they can not 
be classified according to climacteric status. The 
women were also asked to rate their climacteric 
phase themselves by choosing one out of five 
categories. 
Prevalences of vasomotor symptoms were com- 
puted for women in the different climacteric cate- 
gories. Subsequently, a logistic regression analysis 
was performed with the dichotomized scores of 
well-being as the dependent variable and the pres- 
ence of vasomotor symptoms as independent vari- 
able. Well-being scores were dichotomized around 
the median. In an earlier study we reported on the 
relationship between well-being and body mass 
index, smoking, education, the woman’s employ- 
ment status, parity, the way of cohabitation, age 
difference between the partners and the employ- 
ment status of the partner [lo]. In this analysis 
age, education and body mass index were related 
on a P < 0.01 level to one or more of the four 
measures of well-being and were therefore entered 
in the logistic regression equation. Odds ratios 
with 95% confidence intervals were computed for 
the six menopausal statuses defined according to 
last menstrual bleeding as well as for the five 
categories of menopausal status according to the 
women themselves. In this study the odds ratios 
express the likelihood of women with vasomotor 
symptoms compared to women without these 
symptoms of having a score of well-being above 
the median. A relatively high score means a rela- 
tively low level of well-being. 
3. Results 
In Table 1, the prevalence of vasomotor symp- 
toms is shown for the six climacteric statuses 
according to last menstrual bleeding. The preva- 
lence varied from 25.0% in premenopause. to 
69.1% in late perimenopause (peri II) and was 
38.9% in late postmenopause. 
The odds ratios of women with vasomotor 
symptoms as compared to women without these 
symptoms of experiencing a level of well-being 
below the median are also shown in Table 1. 
Premenopausal women with vasomotor symp- 
toms more often experienced a lower level on all 
four measures of well-being compared to women 
without these symptoms. Women with vasomotor 
symptoms had 4.8 (95% CI, 2.3-9.7) times more 
often a lower level of well-being on the ISH. The 
corresponding odds ratio for the SIP social func- 
tioning was 1.9 (95% CI, l.O-3.5), for the SIP 
emotions, feelings and sensations 2.2 (95% CI, 
1.2-4.0) and for SIP intellectual functioning and 
alertness 2.7 (95% CI, 1.4-5.0). 
Early perimenopausal women (peri I) with va- 
somotor symptoms were somewhat more likely to 
experience a lower level of well-being than women 
without these symptoms: the odds ratios being 
slightly higher than 1.0, except for the ISH (odds 
ratio, 2.1; 95% CI, 1.1-4.0). In contrast, late 
perimenopausal women (peri II) with vasomotor 
symptoms less often report a relatively low level 
of well-being on all scales. However, none of these 
odds ratios were statistically significant. 
For early postmenopausal women (post I) no 
association between vasomotor symptoms and the 
SIP intellectual functioning and alertness and the 
SIP emotions, feelings and sensations was found, 
whereas for the ISH and the SIP social function- 
ing odds ratios of 1.9 (95% CI, 0.8-4.8) and 2.9 
(95% CI, 1.2-7.1) respectively were found. 
Among middle postmenopausal women (post II) 
all women with vasomotor symptoms reported a 
relatively lower level of well-being. Finally, for 
late postmenopausal women (post III) with vaso- 
motor symptoms all measures showed an odds 
ratio higher than 1.0. Statistically significant odds 
ratios were established on the ISH (odds ratio, 
2.1; 95% CI, 1.3-3.4) and the SIP social function- 
ing (odds ratio, 1.9; 95% CI, 1.2-3.1) only. 
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Table I 
Prevalence and odds ratios of vasomotor symptoms for menopausal status according to last menstrual bleeding 
Characteristic Menopausal status according to last menstrual bleeding 
---__-- 
Pre Peri I Peri II Post I Post II Post III 
Number 274 226 83 140 153 466 
Prevalence of vasomotor symptoms 25.0% 41.0% 69.1% 61.3% 58.4% 38.9% 
Measure of well-being 
ISH 
Odds Ratio 4.8 2.1 0.6 1.9. 5.8 2.1 
95% CI 2.3-9.1 1.1-4.0 0.2-2.3 0.8-4.8 2.4-14.0 1.333.4 
SIP social functioning 
Odds Ratio 1.9 1.0 0.4 2.9 1.4 1.9 
95% CI 1.0-3.3 0.5-1.8 0.1-1.2 1.227.1 0.6-3.0 1.2-3.1 
SIP emotions, feelings and sensations 
Odds Ratio 2.2 1.5 0.5 0.8 2.0 1.4 
95% CI 1.2-4.0 0.8-2.7 0.2-1.6 0.4-1.9 0.8-4.7 0.9-2.1 
SIP intellectual functioning and alertness 
Odds Ratio 2.7 1.2 0.8 1.0 1.5 1.3 
95% CI 1.4-5.0 0.6-2.1 0.3-2.5 0.4-2.3 0.7-3.5 0.8-2.0 
Odds ratio of women with vasomotor symptoms compared to women without symptoms of being above the median on four 
measures of well-being. A score above the median means a relatively lower level of well-being. Figures are presented separately for 
menopausal status according to last menstrual bleeding. Odds ratios are adjusted for differences in age, education and body mass 
In Table 2 the relationship between vasomotor 
symptoms and the level of well-being is shown for 
the menopausal phases categorized according to 
the women themselves. The same pattern 
emerged. Here too, women with vasomotor symp- 
toms who perceive themselves as not menopausal 
or menopausal long ago had significantly more 
often a relatively low level of well-being, whereas 
women with vasomotor symptoms who perceive 
themselves as in the middle of menopause had 
odds ratios that are notably lower. 
4. Discussion 
Population based studies established no major 
difference in well-being between pre-, peri- and 
postmenopausal women [6-10,121. Studies in 
which a distinction was made between women 
with or without vasomotor symptoms showed a 
considerably lower level of well-being for women 
with these symptoms [13,19]. In this cross-sec- 
tional study we also found a clear relationship 
between vasomotor symptoms and well-being 
which depended on climacteric status. We found 
that pre and (middle and late) postmenopausal 
women with vasomotor symptoms more often 
experienced a relatively low level of well-being 
compared to women without these symptoms. 
However, in contrast to the above mentioned 
studies, a difference in the level of well-being 
between women with and without vasomotor 
symptoms was absent in late perimenopause; the 
phase in which the prevalence of vasomotor 
symptoms is at its peak. 
An explanation for the fact that Oldenhave did 
not detect an absence of the relationship in peri- 
menopausal women may be found in the differ- 
ences between the measurement instruments 
applied to quantify health status. 
In Daly’s recently published study, it was con- 
cluded that the quality of life of women with 
menopausal symptoms may be severely compro- 
mised and that perceived improvements in quality 
of life in users of hormone replacement therapy 
seem to be substantial 1191. The methodology of 
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Table 2 
Prevalence and odds ratios of vasomotor symptoms for menopausal status according to the women themselves 
Characteristic Menopausal status according to the women themselves 
Not reached 
menopause 
Just reached 
menopause 
Middle of 
menopause 
End of menopause Menopause long 
ais0 
Number 265 242 324 224 354 
Prevalence of 11.2% 45.4% 68.3% 58.8% 21.7% 
vasomotor symptoms 
Measure of well-being 
ISH 
Odds Ratio 4.4 2.1 1.5 1.4 2.8 
95% CI 2.0-9.6 1.1-3.9 0.8-2.8 0.7-2.8 1.5.-5.2 
SIP social functioning 
Odds Ratio 2.3 0.7 1.2 1.7 1.8 
95% CI 1.1-4.9 0.4-1.4 0.7-2.1 0.8-3.3 1 .O-3.2 
SIP emotions, feelings and sensations 
Odds Ratio 2.6 1.0 0.8 1.0 1.8 
95% CI 1.3-5.3 0.5-1.7 0.4-1.3 0.5-1.8 1 .o-3.1 
SIP intellectual functioning and alertness 
Odds Ratio 3.8 0.9 0.9 1.3 1.4 
95% CI 1.8-7.8 0.5-1.7 0.551.5 0.7-2.5 0.8-2.4 
Odds ratios of women with vasomotor symptoms compared to women without symptoms of being above the median on four 
measures of well-being. A score above the median means a relatively lower level of well-being. Figures are presented separately for 
menopausal status according to the women themselves. Odds ratios are adjusted for differences in age, education and body mass 
index. 
that study is different from ours. Firstly, women 
who suffered from bothersome complaints mainly 
were recruited whereas we recruited from a gen- 
eral population. Secondly, imagination of (sever- 
ity of) complaints was used, in contrast to actual 
experience in our study. 
This study yielded an unexpected observation: 
vasomotor symptoms were negatively related with 
well-being in all menopausal phases, with the 
exception of the late perimenopausal phase. Al- 
though the prevalence of vasomotor symptoms 
depends on the climacteric status, it is not obvious 
why in late perimenopausal women vasomotor 
symptoms were not related to well-being, whereas 
in pre- and postmenopausal women they were. 
Differences in hormone level could provide an 
explanation. However, no study thus far has 
shown a clear relationship between serum hor- 
mone levels and vasomotor symptoms [20,21]. 
Even if such a relationship exists it would still be 
difficult to explain the absence of a negative im- 
pact of vasomotor symptoms on well-being in 
perimenopausal women. Apart from a biological 
approach we think a social scientific explanation 
may be worthwhile. Social scientists stress the 
importance of the context in which a symptom is 
experienced [22,23]. Aubuchon et al. conclude 
that social expectancies influence the report of 
perimenstrual discomfort. Zola stated that there 
are two ways in which symptoms indicated in one 
part of a population may be ignored in another 
part. Firstly, when a symptom’s prevalence is 
high, this condition may be perceived as the nor- 
mal state. Secondly, it is the fit of certain symp- 
toms with a society’s major values (75% of the 
women in this study agreed with the statement 
‘physical changes in the climacteric are natural’ 
[24]), which accounts for the degree of attention 
they receive. This theory implies that vasomotor 
symptoms will be experienced as ‘normal’ in peri- 
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menopause, whereas the presence of vasomotor 
symptoms in pre- and postmenopausal women 
will be more difficult to understand. This line of 
reasoning is only valid when perimenopausal 
women according to last menstrual bleeding per- 
ceive themselves as such. In fact the results 
about the relationship between vasomotor symp- 
toms and well-being for the climacteric status as 
perceived by the women themselves confirm this 
view. 
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